Treatment for Recurrent HSV-1 Outbreaks
Valacyclovir 2 grams twice daily for one day is the most effective treatment for recurrent HSV-1 outbreaks (cold sores), as it shortens the duration of symptoms by approximately one day compared to placebo. 1
First-Line Treatment Options
Episodic Therapy (for individual outbreaks)
Valacyclovir (preferred):
Famciclovir:
Acyclovir:
Suppressive Therapy (for frequent recurrences)
- Valacyclovir: 1 gram once daily (only antiviral FDA-approved for once-daily suppressive therapy) 1, 6
- Famciclovir: 250 mg twice daily 2, 7
- Acyclovir: 400 mg twice daily 4
Treatment Selection Algorithm
For infrequent outbreaks (≤6 per year):
- Use episodic therapy with valacyclovir 2 grams twice daily for 1 day at first sign of outbreak
- Alternative: famciclovir 1500 mg as a single dose
For frequent outbreaks (>6 per year):
- Consider suppressive therapy with valacyclovir 1 gram once daily
- Alternative: famciclovir 250 mg twice daily
For immunocompromised patients:
- Higher doses and longer treatment duration may be required
- Consider acyclovir 400 mg 3-5 times daily until clinical resolution 4
Special Considerations
Acyclovir-Resistant HSV
For patients with acyclovir-resistant strains:
- Consider foscarnet 40 mg/kg IV every 8 hours until clinical resolution 4, 8
- Topical trifluridine (TFT) may be applied 3-4 times daily for accessible lesions 8
Renal Impairment
Dose adjustments are necessary based on creatinine clearance:
- For creatinine clearance >25 mL/min: Standard dosing
- For creatinine clearance 10-25 mL/min: Reduce frequency (e.g., acyclovir 800 mg every 8 hours) 4
- For creatinine clearance <10 mL/min: Further reduction (e.g., acyclovir 800 mg every 12 hours) 4
Patient Education
- Start treatment at the earliest symptoms before visible lesions appear 1, 3
- Abstain from close contact during active lesions to prevent transmission 4
- Use sunscreen (SPF 15+) to help prevent UV-triggered recurrences 5
- Consistent use of latex condoms can reduce transmission risk 4
Common Pitfalls
- Delayed treatment initiation: Antivirals are most effective when started within the first few hours of symptom onset 1, 3
- Inadequate dosing: Short-course, high-dose therapy has better compliance and similar efficacy to longer courses 3
- Failure to consider suppressive therapy: Patients with frequent recurrences (>6 per year) benefit more from daily suppressive therapy than episodic treatment 7, 6
- Overlooking resistance: Consider acyclovir resistance in immunocompromised patients with poor response to standard therapy 8